No ‘RLD’ in the EEA [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2021-09-10 20:22 (83 d 22:03 ago) – Posting: # 22566
Views: 708

Hi Shahajan,

» […] I wanted to know if there will be no RLD available in EU region…

Lacking an ‘Orange Book’, there is no ‘Reference Listed Drug’ in the [image] European Economic Area.
[image] = [image] [image] [image] [image] [image][image] [image] [image] [image] [image] [image] [image] [image] [image] [image] [image] [image] [image][image] [image] [image] [image] [image] [image] [image] [image] [image]
EEA = [image] + [image] [image] [image]
Read Ohlbe’s post again.

» …for a parenteral solution so how can we proceed for biowaiver for the particular parenteral product because for biowaiver we need to prove similarity between active substances as per GUIDELINE ON THE INVESTIGATION OF BIOEQUIVALENCE (CPMP/EWP/QWP/1401/98 Rev. 1/ Corr **) which states that: […]

Can you be more specific? ‘Parenteral’ is any route of administration which is not oral.
Only – given certain conditions – for aqueous intravenous solutions a biowaiver is possible.

» So how would we proceed in such cases?? shall we proceed with an available different dosage form of the same strength??

See above.

Dif-tor heh smusma 🖖
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

Activity
 Admin contact
21,785 posts in 4,556 threads, 1,547 registered users;
online 7 (0 registered, 7 guests [including 4 identified bots]).
Forum time: Friday 17:25 CET (Europe/Vienna)

A drug is that substance which, when injected into a rat,
will produce a scientific report.    Anonymous

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5